All In Biotech

Drug Trial Radar · NCT05090371

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light Levels (SOSTOS)

Last checked: Nov 20, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 136 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

136

Actual

Start

Mar 2, 2022

Primary completion

Apr 13, 2027

Study completion Apr 13, 2027

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Oct 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) level predicts enhanced benefit from a switch to ofatumumab.

Conditions

  • Relapsing-Remitting Multiple Sclerosis

Interventions

  • OfatumumabDrug

    3 loading doses followed by administration every 4 weeks as per label

  • Disease modifying treatment (DMT)Drug

    Other DMT with approved label use for treatment which participants were on at least 6 months prior to Screening

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants achieving NEDA-3 (No Evidence of Disease Activity-3)Time frame: Months 3 to 15

Locations

43 sites in 2 countries. Site status is shown where the registry gives one.

  • Alabama Neurology Associates PC

    Birmingham, Alabama

  • North Central Neurology Associates PC

    Cullman, Alabama

  • Radiant Research Chandler

    Chandler, Arizona

  • Arizona Neuroscience Research LLC

    Phoenix, Arizona

  • University of California at Los Angeles

    Torrance, California

  • Neurology of Central FL Res Ctr

    Altamonte Springs, Florida

  • S And D Clinical Research

    Cape Coral, Florida

  • Homestead Assoc In Research Inc

    Homestead, Florida

  • Neurology Associates PA

    Maitland, Florida

  • Orlando Health Clinical Trials

    Orlando, Florida

  • Emerald Coast Neurology

    Pensacola, Florida

  • University Of South Florida

    Tampa, Florida

  • Kootenai Health

    Coeur d'Alene, Idaho

  • Neuro Medial Clinic of Central Louisiana

    Alexandria, Louisiana

  • International Neurorehab Institute

    Lutherville, Maryland

  • Reliant Medical Group

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • Memorial Healthcare

    Owosso, Michigan

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • St Barnabas Medical Center

    Livingston, New Jersey

  • Jersey Shore University Medical Ctr

    Neptune City, New Jersey

  • SUNY Upstate Medical Center

    Syracuse, New York

  • University Of NC At Chapel Hill

    Chapel Hill, North Carolina

  • Piedmont HealthCare

    Charlotte, North Carolina

  • Velocity Clinical Research

    Raleigh, North Carolina

  • Palmetto Clinical Research

    Summerville, South Carolina

  • Sibyl Wray MD Neurology PC

    Knoxville, Tennessee

  • Clinical Trial Network

    Houston, Texas

  • Neuro Mind Clinical Trials Ltd Co

    Katy, Texas

  • Covenant Medical Group

    Lubbock, Texas

  • West Texas Cancer Center

    Odessa, Texas

  • Tranquil Clinical Research

    Webster, Texas

  • Sentara Neuroscience Institute

    Virginia Beach, Virginia

  • Evergreen Health Multiple Sclerosis Center

    Kirkland, Washington

  • Swedish Medical Center

    Seattle, Washington

  • Aurora BayCare Medical Center

    Green Bay, Wisconsin

  • Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Novartis Investigative Site

    Edmonton, Alberta, Canada

  • Novartis Investigative Site

    Burnaby, British Columbia, Canada

  • Novartis Investigative Site

    Vancouver, British Columbia, Canada

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.